Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-20

Clinical Trial Update: Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study update investigating the bioavailability and effects of food on HRS-7535 tablets using different formulation processes in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: NOT_YET_RECRUITING